company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5848000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5848000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,613000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2203000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3017000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3017000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4120000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5062000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,930000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,930000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5688000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5688000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5688000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3601000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5314000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,120000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5434000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,516000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1268000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6174000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-10000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6184000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9022000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9017000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9017000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,340000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,340000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,340000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3173000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6405000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6405000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,573000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,399000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5422000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5422000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-200000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,100000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-125000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-125000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 10:24:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5547000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3096000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3096000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,519000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-113000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2680000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2680000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9340000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,224000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9125000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9125000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,30809000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1340000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32149000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32149000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20344000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10247000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10247000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,472000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2668000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7095000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7095000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-200000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,253000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,39000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,39000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-75000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1756000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1681000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1681000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5375000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8375000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,246000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8621000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,528000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,453000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7626000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,1000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7625000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-201000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5253000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5043000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5043000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2582000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9114000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9114000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,646000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-91000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8549000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8549000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5236000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,235000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5003000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5003000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:36:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13552000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1504000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1504000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2201000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-104000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3800000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3800000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6027000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9228000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3200000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3200000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-600000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5475000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5475000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,545000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1926000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6848000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6848000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6012000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5996000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5996000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-852000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,16093000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16093000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-22183000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,516000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5566000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5566000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5571000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2055000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2055000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,581000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-674000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2138000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2138000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-45000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5637000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,80393000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,93000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,74849000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,74849000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:02:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,72666000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11358000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11358000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,638000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3416000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7292000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7292000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24403000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,109000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-24294000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-24294000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,125000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,122000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,122000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-31464000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15651000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15651000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,741000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2258000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12640000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12640000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24294000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24290000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24290000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,209000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,209000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,209000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11859000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17668000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17668000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3993000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1406000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12249000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12249000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-297000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-297000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-297000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,5640000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-5640000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,504000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,504000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,504000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12042000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13530000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13530000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2552000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,900000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10046000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10046000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-221000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49772000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,107000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49886000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49886000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7460000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,115057000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1896000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,109493000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,109493000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:34:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,49561000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22414000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22414000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,56000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2604000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2183000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17571000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17571000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-565000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,4501000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,173000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4109000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4109000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-65000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,264000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,199000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,199000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13263000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35289000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35289000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,97000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8240000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7166000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19786000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19786000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-413000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4454000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15344000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10477000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10477000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1447000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1447000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1447000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7862000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40285000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40285000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,121000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13561000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6995000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33598000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33598000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-290000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22639000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22303000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22303000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,7525000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-7525000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1447000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1447000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1447000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9848000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27739000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27739000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,138000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4321000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11996000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35276000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35276000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-61000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11508000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11447000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11447000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,118284000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,97000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,118381000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,118381000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:05:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,94552000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26877000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26877000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,145000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-42000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3247000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15243000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38770000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38770000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-103000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-103000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-103000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1326000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1326000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-37547000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30745000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30745000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,148000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-60000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4575000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2740000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28822000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28822000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-268000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-268000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-268000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-29081000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37784000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37784000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,165000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11296000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-23856000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,25590000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24589000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24589000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2345000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2345000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2345000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,125000000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,125016000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,125016000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,98082000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40964000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40964000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,261000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,15809000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3300000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6031000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27728000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27728000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2037000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2037000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2037000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:36:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-29759000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14870000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14870000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,138000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,138000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,138000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14735000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41696000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41696000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,256000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-61000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17387000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,460000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23654000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23654000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-24000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-24000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,54000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,54000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,54000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-23624000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33784000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33784000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,229000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-34000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12742000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,521000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20352000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20352000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20362000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23016000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23016000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,229000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-62000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3889000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7003000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25963000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25963000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-28000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5080000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5062000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5062000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:23:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20901000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-86497000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-86497000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,230000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,62905000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3746000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1386000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18230000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18194000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-420000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-420000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-420000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,28000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,68133000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,247000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,68408000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,68232000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,49618000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23498000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23498000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,230000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-62000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4736000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10533000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29127000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29156000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-756000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-756000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-756000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3384000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26528000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30429000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30429000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,248000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-60000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-10118000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,20190000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20169000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20176000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-81000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-81000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-81000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-216000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20473000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21896000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21896000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,252000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-62000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7780000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19501000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33430000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33430000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-78000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-78000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-78000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,69000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,69000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,69000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:23:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-33439000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21518000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21518000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,224000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1255000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7488000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21316000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21363000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,26000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,26000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,26000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10000000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,708000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10708000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10708000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10629000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16995000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16995000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,251000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2153000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5609000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14451000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23433000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23385000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15000000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,73000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,15073000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15073000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8312000.0
